Table 6.
Response Evaluation Criteria in Solid Tumors Tumor Response Rates by Presence/Absence of Specific Mutations
| Clinical response by subgroups (patients with mutational interrogation only) | |
|---|---|
| Histological subtype | |
| Follicular | 0/2 (0%) |
| Hürthle cell | 2/6 (33.3%) |
| Papillary | 2/8 (25.0%) |
| BRAF mutation | |
| Yes | 1/5 (20.0%) |
| No | 3/11 (27.3%) |
| BRAF or HRAS mutation | |
| Yes | 2/7 (28.6%) |
| No | 2/9 (22.2%) |
| TP53 mutation | |
| Yes | 0/3 (0%) |
| No | 4/13 (30.8%) |